What is polymorphous light eruption?
Polymorphous light eruption — commonly abbreviated as PMLE and sometimes called polymorphic light eruption — is the most common sun-related skin condition, estimated to affect between 10 and 20 percent of the population in temperate climates. Despite its prevalence, it is frequently misidentified as a sunburn, prickly heat, or a general “sun allergy,” and many individuals manage it without ever receiving a formal diagnosis.
The name reflects one of its defining characteristics: the rash it produces is polymorphous — taking multiple different forms — varying in appearance between individuals, though in any one individual the rash tends to be consistent in its appearance from episode to episode. Presentations include small red bumps (papules), fluid-filled blisters (vesicles), larger raised plaques, or a combination of these, occurring on sun-exposed skin.
PMLE is a delayed hypersensitivity reaction — it does not produce immediate hives like solar urticaria but develops hours after sun exposure, typically within 30 minutes to several hours, and persists for one to several days if sun exposure continues. It is thought to involve an immune response to a UV-modified skin antigen — a photoantigen that the immune system recognizes as foreign and mounts a delayed T-cell mediated reaction against. The precise nature of this photoantigen remains incompletely characterized.
PMLE is significantly more common in women than men and tends to first appear in the second or third decade of life, though it can develop at any age. It is most prevalent in fair-skinned individuals and in populations living at northern latitudes where the skin is less adapted to high UV levels, though it occurs across all skin types.
One of the most clinically distinctive features of PMLE is its seasonal pattern and the phenomenon of hardening. Reactions are most severe in spring and early summer, when UV intensity increases after winter and the skin has not yet adapted to higher light levels. With repeated sun exposure over the season, many individuals find their skin becomes progressively less reactive — a process known as hardening or tolerance induction — and symptoms may diminish or resolve entirely by mid-summer, only to return the following spring. This seasonal pattern of onset and improvement is one of the most reliable diagnostic features of PMLE.
PMLE sits within the broader category of sun allergy conditions.
Symptoms
PMLE symptoms develop hours after sun exposure rather than immediately, distinguishing it clearly from solar urticaria and from phototoxic reactions which tend to resemble severe sunburn.
Skin symptoms:
- Itchy red bumps (papules) on sun-exposed skin — the most common presentation
- Fluid-filled blisters (vesicles) in some individuals
- Raised, itchy plaques
- Redness and inflammation
- In some individuals, a combination of these forms
- Symptoms confined to sun-exposed areas — arms, chest, legs, and the V of the neck most commonly
- The face is often relatively spared despite being sun-exposed — thought to reflect ongoing low-level UV adaptation in habitually exposed facial skin
Systemic symptoms:
- Itching — often intense and the most distressing symptom
- Burning sensation of the skin
- Mild fatigue or malaise in some individuals during flares
PMLE does not typically cause systemic symptoms such as anaphylaxis, throat swelling, or cardiovascular compromise — the absence of these features distinguishes it from solar urticaria.
Seasonal pattern:
- Reactions most severe in spring and early summer after minimal winter UV exposure
- Progressive improvement with repeated sun exposure over the season
- Resolution by mid to late summer in many individuals
- Recurrence the following spring
Triggers and modifying factors
UV radiation
UVA is the primary trigger for PMLE in most affected individuals, which has practical implications for management — many conventional sunscreens provide better UVB than UVA protection, and glass transmits UVA, meaning some individuals can develop PMLE through car or home windows. UVB can also trigger PMLE in some individuals, and in some cases both UVA and UVB are implicated.
Sun exposure pattern
PMLE tends to be triggered by intermittent intense sun exposure — a day at the beach or a holiday in a sunny climate — rather than the gradual daily sun exposure that characterizes a hardened skin response. This is why PMLE is sometimes called “holiday rash” and why it is frequently first noticed during travel to sunny destinations.
Medications and photosensitizers
Certain medications and topical products can lower the threshold for PMLE reactions, including some antibiotics, diuretics, and fragrances. Reviewing current medications is worth considering if PMLE reactions appear to have worsened without obvious environmental explanation.
Genetic predisposition
PMLE has a recognized familial tendency, and a positive family history of the condition is a useful supporting feature when considering the diagnosis.
Diagnosis
PMLE is primarily a clinical diagnosis based on history and physical examination. Formal testing is not always required but can be helpful when the diagnosis is uncertain or when other photosensitivity conditions need to be excluded.
Clinical history
A detailed history of the timing and appearance of the rash in relation to sun exposure, its seasonal pattern, which body areas are affected, and whether it improves with repeated sun exposure over the season is the most informative diagnostic tool. The characteristic combination of delayed onset, spring and early summer predominance, and seasonal improvement with sun exposure is highly suggestive of PMLE.
Phototesting
Phototesting — controlled exposure to measured doses of UV light — can be used to provoke a PMLE reaction under clinical conditions and confirm the diagnosis, as well as to identify the action spectrum responsible. This is particularly useful when the clinical picture is atypical or when solar urticaria needs to be excluded. Unlike solar urticaria, PMLE phototesting typically requires repeated daily exposures over several days before a reaction can be provoked.
Skin biopsy
A skin biopsy of an active PMLE lesion can support the diagnosis by showing a characteristic pattern of dermal inflammation, though the histological findings are not specific enough to be diagnostic on their own.
Exclusion of other conditions
Because PMLE shares features with several other conditions — including lupus erythematosus, photoallergic contact dermatitis, and solar urticaria — blood tests including antinuclear antibody (ANA) testing may be ordered to exclude lupus, and photopatch testing may be performed to rule out photoallergic contact dermatitis when sunscreen or topical product use is a possible contributing factor.
Treatment
Photoprotection
Broad-spectrum sun protection is the cornerstone of PMLE prevention. Because UVA is the primary trigger in most patients, broad-spectrum sunscreens with strong UVA protection are specifically important — products containing zinc oxide or titanium dioxide as physical filters, or avobenzone as a chemical UVA filter, provide the most reliable UVA coverage. A minimum SPF 50 broad-spectrum sunscreen applied generously and reapplied every two hours during outdoor activity is recommended.
Additional photoprotective measures include:
- Sun-protective clothing with a high UPF rating
- Wide-brimmed hats
- Seeking shade during peak UV hours between 10am and 4pm
- UV-blocking window film for car windows in individuals who react through glass
Hardening therapy
For individuals with significant PMLE who want to be able to tolerate outdoor activities in spring and summer, deliberate hardening therapy in early spring can be highly effective. This involves controlled, graduated sun exposure — either through supervised narrowband UVB phototherapy in a clinical setting, or through a structured program of brief daily outdoor sun exposure starting in early spring before UV levels peak — to induce skin tolerance before the main summer season.
Narrowband UVB phototherapy administered two to three times per week for four to six weeks in early spring is an effective and well-established approach that significantly reduces or prevents PMLE reactions in many patients during the subsequent summer season. The protective effect lasts through the summer but does not persist over winter, so the course may need to be repeated annually.
Topical corticosteroids
Topical corticosteroid creams or ointments applied to active PMLE lesions reduce inflammation and relieve itching, shortening the duration and severity of individual flares. They do not prevent future reactions.
Oral corticosteroids
For severe acute PMLE flares — particularly those triggered by unavoidable sun exposure such as an important outdoor event or holiday — a short course of oral corticosteroids can rapidly suppress the reaction. This is not a long-term management strategy but a useful rescue treatment for specific situations.
Antihistamines
Oral antihistamines can help manage the itching associated with PMLE flares, though they do not address the underlying immune mechanism and have limited efficacy in preventing reactions. They are most useful as a symptomatic adjunct during active flares.
Hydroxychloroquine
In individuals with more severe or refractory PMLE, hydroxychloroquine — an antimalarial medication with immunomodulatory properties — has been used with reported benefit. It is typically considered when photoprotection and topical treatments are insufficient and phototherapy is not available or tolerated.
Afamelanotide
Afamelanotide, a synthetic analogue of alpha-melanocyte stimulating hormone that induces melanin production and provides a degree of photoprotection, has been studied in PMLE with some evidence of benefit. It is not widely available for this indication but represents an emerging treatment option.
If you are in the NYC area and experience a recurring itchy rash after sun exposure — particularly in spring and early summer — our allergists can assess whether PMLE is the cause and develop a management plan including photoprotection guidance and hardening therapy. Book an appointment online or call (212) 686-6321.
Frequently asked questions
Is polymorphous light eruption the same as a sun allergy?
PMLE is the most common condition described as a sun allergy, but it is one of several distinct sun-related skin conditions grouped under that term. See our sun allergy page for an overview of the full range of conditions including solar urticaria, photoallergic contact dermatitis, and phototoxic reactions, and how to distinguish between them.
Why does my sun rash get better as summer goes on?
This is the hallmark of PMLE — the phenomenon of hardening or tolerance induction. Repeated low-level UV exposure gradually adapts the immune response in the skin, reducing its reactivity to the photoantigen thought to trigger PMLE. This natural hardening process explains why many individuals with PMLE are most affected in spring after winter, improve through the summer, and then find reactions return the following spring when their skin has de-hardened over winter.
Can I get PMLE from a sunbed?
Yes. Artificial UV sources including sunbeds can trigger PMLE in sensitized individuals. Some people with PMLE deliberately use brief sunbed sessions in early spring as a form of self-administered hardening therapy, though this approach carries the well-documented risks of UV tanning devices including skin aging and skin cancer risk and is not recommended. Supervised narrowband UVB phototherapy in a clinical setting achieves the same hardening effect with a more controlled and safer UV exposure profile.
Is PMLE related to lupus?
PMLE and lupus erythematosus can look similar clinically — both cause sun-triggered facial and skin reactions — and the two conditions can be difficult to distinguish on history alone. Blood tests including ANA and anti-double stranded DNA antibody testing can help exclude lupus when the diagnosis is uncertain. Some research has also suggested a biological overlap etween PMLE and lupus, with PMLE occasionally representing an early or localized form of cutaneous lupus in a small proportion of patients. If lupus is a concern, formal evaluation including blood testing is warranted.
Does PMLE get better with age?
Many individuals find that PMLE improves over years — either becoming less severe or resolving entirely. The mechanism is not fully understood but may reflect gradually increasing skin adaptation to UV exposure with age and cumulative sun exposure. Studies suggest that a significant proportion of individuals with PMLE report improvement over a 10 to 15 year follow-up period. This natural history of gradual improvement is reassuring for newly diagnosed patients.
Can children get PMLE?
Yes, though PMLE most commonly first appears in young adults. Childhood PMLE is recognized and presents with the same characteristic pattern of delayed spring and early summer sun-triggered rash. Management in children follows the same principles as in adults — photoprotection as the primary strategy, with topical corticosteroids for active flares and supervised phototherapy for more severe cases where appropriate.